Bionano Genomics, Inc.
BNGO
$4.00
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 51.82% | 40.26% | -39.30% | -62.26% | -75.34% |
| Total Depreciation and Amortization | 2.26% | 17.90% | 13.37% | 26.63% | 41.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.38% | -67.36% | 278.83% | 294.85% | 317.98% |
| Change in Net Operating Assets | 129.80% | 71.81% | 80.84% | 70.33% | 47.13% |
| Cash from Operations | 44.94% | 29.04% | 20.98% | 3.08% | -0.29% |
| Capital Expenditure | 93.91% | 64.74% | 64.77% | 47.36% | 47.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 100.00% | 100.31% | 100.31% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 187.12% | -86.92% | -44.55% | -44.22% | -77.91% |
| Cash from Investing | 205.65% | -83.03% | -17.35% | -17.99% | -70.81% |
| Total Debt Issued | -77.50% | -- | -- | -- | -- |
| Total Debt Repaid | -630.16% | -165,938.64% | -170,763.41% | -120,200.00% | -25,030.56% |
| Issuance of Common Stock | -23.14% | 5.02% | -9.05% | 49.31% | 144.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 32.68% | -1,886.30% | -1,476.61% | -1,462.73% | -2,489.10% |
| Cash from Financing | -112.02% | 11.94% | 3.49% | 104.25% | 394.70% |
| Foreign Exchange rate Adjustments | -110.77% | -56.31% | 200.00% | 250.00% | 271.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -168.25% | -478.92% | 155.25% | 159.63% | 167.38% |